Small-Cap Stock Watch: Key Catalysts This Week (February 17–20)

From corporate updates to investor events, we’ve tracked the full scope of small-cap catalysts slated for the week ahead.

--

Companies with Material Events This Week

● SEGG — Has agreed to binding terms to acquire at least a majority interest in Veloce Media Group, with completion scheduled for Tuesday, February 17, 2026. The transaction values Veloce at approximately $61 million (£45 million) and is expected to contribute over $20 million in additional annual revenue beginning in Q1 2026.

● INVZ — InnovizSMART will be demonstrated at the Defense.tech Expo for Homeland Security taking place February 17–18, 2026, at Tel Aviv Expo, following recent deployments across Israel over the past three months.

● LTRN — CEO and President Panna Sharma will present at the 7th Glioblastoma Drug Development Summit from February 17–19, 2026, in Boston, Massachusetts.

● COYA — Will host a live webinar on February 17, 2026, at 3:00 p.m. ET / 12:00 p.m. PT focused on the evolving ALS treatment landscape.

● NHTC — Declared a quarterly cash dividend of $0.10 per share payable on February 27, 2026, to stockholders of record as of February 17, 2026.

● PERF — Will participate in DeveloperWeek 2026 Hackathon from February 18–20, 2026, at the San Jose Convention Center.

● RCEL — Will host an investor webinar on February 18, 2026, at 2:00 p.m. PST (February 19, 2026, at 9:00 a.m. AEDT).

● ACB — Will ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, at the Nasdaq MarketSite in New York.

● IGC — CEO Ram Mukunda and CCO Claudia Grimaldi will participate in a fireside chat hosted by Ascendiant Capital Markets on February 18, 2026, at 1:00 p.m. ET.

● INO — Will present at the AACR Immuno-Oncology Conference in Los Angeles on Wednesday, February 18, 2026, during Poster Session A from 7:30–10:00 p.m. PT.

● CLDI — Will present data at the AACR Immuno-Oncology Conference taking place February 18–21, 2026, in Los Angeles, California.

● NOTE — Will host a live discussion on February 18, 2026, at 11:00 a.m. ET regarding its expansion into political prediction markets.

● TYGO — Engineering leaders will preview a new real-time commissioning system at IESNA Flagship (Intersolar) tradeshow from February 18–20, 2026, in San Diego, California.

● BLZE — Will participate in DeveloperWeek 2026 from February 18–20, 2026, in San Jose, California, including a session led by Troy Liljedahl on AI infrastructure.

● AGEN — Will present new translational and clinical biomarker analyses at the AACR Immuno-Oncology Conference from February 18–21, 2026, in Los Angeles, California.

● ALLO — Will participate in Citi’s 2026 Virtual Oncology Leadership Summit on Wednesday, February 18, 2026, at 9:15 a.m. PT / 12:15 p.m. ET.

● ASBP — Will participate in The Sports & Active Nutrition Summit USA from February 18–20, 2026, in San Diego, California.

● ALTS — Will attend and participate in the inaugural World Liberty Forum at Mar-a-Lago on February 18, 2026.

● UCAR — Will present at the OTC Markets AI & Technology Investor Conference on February 19, 2026, at 11:00 a.m. ET and host one-on-one meetings February 19–24, 2026.

● CRBU — Will participate in Citi’s 2026 Virtual Oncology Leadership Summit on February 19, 2026, including a fireside chat at 10:45 a.m. ET.

● TRX — Will participate in Renmark’s Virtual Non-Deal Roadshow on February 19, 2026, at 9:00 a.m. CST / 10:00 a.m. EST.

● AIM — CEO Thomas K. Equels will participate in a Virtual Investor Closing Bell Event on February 19, 2026, at 4:00 p.m. ET.

● UP — CEO George Mattson will present at the Barclays Industrial Select Conference in Miami on February 19, 2026, at 10:25 a.m. ET.

● TVRD — Will participate in the JonesTrading C-Suite Fireside Chat Series on Wednesday, February 19, 2026, at 11:00 a.m. EST.

● NWL — President and CEO Chris Peterson and CFO Mark Erceg will present at the CAGNY Conference on Friday, February 20, 2026, at 11:00 a.m. ET.

● NXDT — Declared a quarterly distribution of $0.15 per share payable on March 31, 2026, to shareholders of record on February 20, 2026.

● CADL — Chief Scientific Officer Francesca Barone will present at the 7th Annual Glioblastoma Drug Development Summit from February 17–19, 2026, in Boston, Massachusetts.

● NMG — Will participate in Natural Resources Canada’s trade and diplomatic mission across Europe from February 16–20, 2026.

● BIVI — Will present two abstracts at the American College of Psychiatrists Annual Meeting from February 18–22, 2026, in Bonita Springs, Florida.

● PALI — Will present at the 21st Congress of ECCO, held February 18–21, 2026, in Stockholm, Sweden, including a poster session on February 20, 2026, from 12:40–13:40 CET.

● MNDR — Faces a February 18, 2026 Long-Stop Date to execute a definitive Share Purchase Agreement under its November 19, 2025 MOU with PPG PP GRID SDN. BHD. to acquire two AI-optimized data centres in Malaysia for up to US$120 million in Class A shares. The agreement included a US$1.5 million deposit credited toward the purchase price, which must be refunded by February 25, 2026 if the SPA is not completed. The acquisition is intended to strengthen MNDR’s AI-driven healthcare and digital infrastructure platform.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.